The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J01 | Antibacterials for systemic use | |
3
|
J01F | Macrolides, lincosamides and streptogramins | |
4
|
J01FF | Lincosamides |
| Code | Title | |
|---|---|---|
| J01FF01 | Clindamycin | |
| J01FF02 | Lincomycin |
| Active Ingredient |
|---|
|
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. |
|
Lincomycin is an antibiotic produced by fermentation of Streptomyces lincolnensis. Lincomycin inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome. |
| Document | Type | Information Source | |
|---|---|---|---|
| CLINDAHEXAL Capsule | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| DALACIN C Capsule | MPI, EU: SmPC | Medicines and Medical Devices Safety Authority (NZ) | |
| DALACIN CREAM Vaginal Cream | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| LINCOCIN Solution for injection | MPI, EU: SmPC | Pharmaceutical Benefits Scheme (AU) |